3.57
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Galectin Therapeutics Inc Borsa (GALT) Ultime notizie
Top Risks to Consider Before Buying Galectin Therapeutics Inc. StockJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - Newser
Galectin Therapeutics Inc. stock retracement – recovery analysisEarnings Recap Summary & Consistent Income Trade Ideas - Newser
Comparing Galectin Therapeutics Inc. in custom built stock radarsWeekly Gains Summary & Growth Oriented Trading Recommendations - Newser
Quantitative breakdown of Galectin Therapeutics Inc. recent moveBull Run & Growth-Oriented Investment Plans - Newser
What makes Galectin Therapeutics Inc. stock price move sharplyJuly 2025 Breakouts & Verified Entry Point Signals - Newser
why galectin therapeutics inc. stock attracts strong analyst attentionQuarterly Trade Summary & Community Consensus Trade Alerts - Newser
Can Galectin Therapeutics Inc. Regain Lost Ground This QuarterMarket Trend Report & Free Real-Time Market Sentiment Alerts - newsyoung.net
Is Now The Right Time To Buy Galectin Therapeutics Inc (NASDAQ: GALT) Stock? - stocksregister.com
Signal strength of Galectin Therapeutics Inc. stock in tech scannersExit Point & Momentum Based Trading Ideas - Newser
Galectin Therapeutics Reports Reduced Losses in Q2 2025 - TipRanks
GALECTIN THERAPEUTICS INC SEC 10-Q Report - TradingView
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2025 and Provides Business Update - Yahoo Finance
Strategies to average down on Galectin Therapeutics Inc.Market Risk Report & Verified Short-Term Plans - Newser
What recovery options are there for Galectin Therapeutics Inc.2025 Analyst Calls & Growth Oriented Trading Recommendations - Newser
Combining price and volume data for Galectin Therapeutics Inc.Market Performance Summary & Low Risk Investment Opportunities - Newser
Will Galectin Therapeutics Inc. stock recover after recent dropIPO Watch & Weekly Top Stock Performers List - Newser
What data driven models say about Galectin Therapeutics Inc.’s futureProfit Target & Low Risk Entry Point Guides - Newser
How institutional ownership impacts Galectin Therapeutics Inc. stockEarnings Beat & Stepwise Trade Signal Implementation - Newser
Galectin Therapeutics (NASDAQ:GALT) Share Price Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Earnings visualization tools for Galectin Therapeutics Inc.Free Capital Growth With Controlled Risk Picks - Newser
Predicting Galectin Therapeutics Inc. trend using moving averagesChart Scanner for Swing Trade Timing - Newser
Galectin Therapeutics Inc. stock trend outlook and recovery pathLow Drawdown Picks with Weekly Updates - Newser
What the charts say about Galectin Therapeutics Inc. todayRisk/Reward Optimization Entry Point Analysis - Newser
How Galectin Therapeutics Inc. stock performs during market volatilityDaily Swing Candidate Analysis with Chart Patterns - Newser
Does Galectin Therapeutics Inc. show high probability of reboundFree Buy Signal Based on Chart Analysis - Newser
Galectin Therapeutics (GALT) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Galectin GALT 2025Q2 Earnings Preview Upside Potential on Immunotherapy Advancements - AInvest
Galectin Therapeutics Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):